Editorial


An important piece of the puzzle for understanding the benefits of concomitant ablation of atrial fibrillation in cardiac surgery

Anders Albåge

Abstract

Surgical treatment of atrial fibrillation (AF) has come a long way since the early days of the Cox-maze III procedure (CM-3), introduced by James Cox in the late 80’s (1). Back then, there was no catheter ablation therapy available for AF and CM-3 was offered as a stand-alone treatment for drug-refractory AF in carefully selected patients.

Download Citation